-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FQAGB8CShRLnw9YT7lOV0iO+msogk8KzrSTzbFZdJAt7h+K04c4/Bsxsnj+qzzs0 5RaUdcw8FRVZP28hz3NViQ== 0000914062-99-000014.txt : 19990121 0000914062-99-000014.hdr.sgml : 19990121 ACCESSION NUMBER: 0000914062-99-000014 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19981218 FILED AS OF DATE: 19990120 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CRYOLIFE INC CENTRAL INDEX KEY: 0000784199 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 592417093 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: SEC FILE NUMBER: 001-13165 FILM NUMBER: 99508534 BUSINESS ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W STREET 2: STE 142 CITY: KENNESAW STATE: GA ZIP: 30144 BUSINESS PHONE: 7704193355 MAIL ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W STREET 2: STE 142 CITY: KENNESAW STATE: GA ZIP: 30144 COMPANY DATA: COMPANY CONFORMED NAME: FRONK DAVID CENTRAL INDEX KEY: 0001076390 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] OFFICER IRS NUMBER: 581297864 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A BUSINESS ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD NW CITY: KENNESAW STATE: GA ZIP: 30144 BUSINESS PHONE: 7704193555 MAIL ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD CITY: KENNESAW STATE: GA ZIP: 30144 3/A 1 FORM 3/A - 12/18/98 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 1. Name and Address of Reporting Person FRONK, DAVID 1655 Roberts Blvd, NW Kennesaw, GA 30144 2. Date of Event Requiring Statement (Month/Day/Year) 12/18/98 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Issuer Name and Ticker or Trading Symbol CryoLife, Inc. CRY 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) ( ) Director ( ) 10% Owner (X) Officer (give title below) ( ) Other (specify below) Vice President - Clinical Research 6. If Amendment, Date of Original (Month/Day/Year) 1/13/99 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person
___________________________________________________________________________________________________________________________________ Table I -- Non-Derivative Securities Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1. Title of Security |2. Amount of |3. Ownership |4. Nature of Indirect | | Securities | Form: | Beneficial Ownership | | Beneficially | Direct(D) or | | | Owned | Indirect(I) | | ___________________________________________________________________________________________________________________________________| Common Stock |1,183 Shares |D | | - -----------------------------------------------------------------------------------------------------------------------------------| ___________________________________________________________________________________________________________________________________| ___________________________________________________________________________________________________________________________________ Table II -- Derivative Securitites Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1.Title of Derivative |2.Date Exer- |3.Title and Amount | |4. Conver-|5. Owner- |6. Nature of Indirect | Security | cisable and | of Underlying | |sion or |ship | Beneficial Ownership | | Expiration | Securities | |exercise |Form of | | | Date(Month/ |-----------------------|---------|price of |Deriv- | | | Day/Year) | |Amount |deri- |ative | | | Date | Expira- | |or |vative |Security: | | | Exer- | tion | Title |Number of|Security |Direct(D) or | | | cisable | Date | |Shares | |Indirect(I) | | ___________________________________________________________________________________________________________________________________| Incentive Stock Option |(1) |9/5/03 |Common Stock |5,000 |14.1875 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| Incentive Stock Option |(2) |6/18/04* |Common Stock |10,000 |12.00 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| ___________________________________________________________________________________________________________________________________|
Explanation of Responses: (1) Exercisable in five equal annual installments of 1,000 shares each beginning on 3/5/99. (2) Exercisable in five equal annual installments of 2,000 shares each beginning on 12/18/99. * This amendment is filed to correct the expiration date of the option, which was reported as 12/18/08 in the original Form 3. SIGNATURE OF REPORTING PERSON David Fronk DATE January 19, 1999 -----END PRIVACY-ENHANCED MESSAGE-----